Chemical composition andin vitrocytotoxic effects of the essential oil fromNectandra leucanthaleaves / Simone dos S. Grecco, Euder Glendes A. Martins, Natália Girola, Carlos R. de Figueiredo, Alisson L. Matsuo, Marisi G. Soares, Bruno de C. Bertoldo, Patricia Sartorelli, João Henrique G. Lago
Abstract Context: Nectandra (Lauraceae) species have been used in folk medicine as an antidiarrheal, analgesic, antifungal, etc., and have many pharmacological proprieties. Objective : Investigation of the chemical composition and cytotoxicity of essential oil from Nectandra leucantha Nees & Mart. leaves. This is the first study involving N. leucantha reported in the literature. Material and methods : The essential oil of N. leucantha leaves was obtained by hydrodistillation. Its chemical composition was determined using a combination of GC/FID, GC/MS, and determination of Kovats index (KI). In vitro cytotoxic activity was evaluated against six cancer cell lines – murine melanoma (B16F10-Nex2), human glioblastome (U-87), human cervical carcinoma (HeLa), human colon carcinoma (HCT), human breast adenocarcinoma (MCF7), and human cervical tumor (Siha) as well as against one non-tumorigenic cell line – human foreskin fibroblast (HFF). Results : Thirty-three compounds were identified primarily sesquiterpenes (81.41%), the main compounds being bicyclogermacrene (28.44%), germacrene A (7.34%), spathulenol (5.82%), and globulol (5.25%). Furthermore, monoterpenes were also found in the analyzed oil (12.84%), predominantly α- and β-pinenes (6.59 and 4.57%, respectively). The crude essential oil displayed significant cytotoxic activity against B16F10-Nex2 (IC 50 33 ± 1 μg/mL) and U87 (IC 50 75.95 ± 0.03 μg/mL) and HeLa (IC 50 60 ± 12 μg/mL) cell lines. The main identified compound, bicyclogermacrene, displayed IC 50 ranging from 3.1 ± 0.2 to 21 ± 6 μg/mL. Discussion and conclusion : The results indicate that the crude oils from leaves of N. leucantha displayed cytotoxic activity being bicyclogermacrene, the main compound identified in the crude oil responsible, at least in part, for this potential.
| Medienart: |
E-Artikel |
|---|
| Erscheinungsjahr: |
2015 |
|---|---|
| Erschienen: |
2015 |
| Enthalten in: |
Zur Gesamtaufnahme - volume:53 |
|---|---|
| Enthalten in: |
Pharmaceutical biology - 53(2015), 1, Seite 133- |
| Sprache: |
Englisch |
|---|
| Beteiligte Personen: |
Grecco, Simone dos S [VerfasserIn] |
|---|
| Links: |
FID Access [lizenzpflichtig] |
|---|
| Umfang: |
1 Online-Ressource (5 p) |
|---|
| doi: |
10.3109/13880209.2014.912238 |
|---|
| funding: |
|
|---|---|
| Förderinstitution / Projekttitel: |
|
| PPN (Katalog-ID): |
KFL001102869 |
|---|
| LEADER | 01000caa a22002652 4500 | ||
|---|---|---|---|
| 001 | KFL001102869 | ||
| 003 | DE-627 | ||
| 005 | 20230623202307.0 | ||
| 007 | cr uuu---uuuuu | ||
| 008 | 210608s2015 xx |||||o 00| ||eng c | ||
| 024 | 7 | |a 10.3109/13880209.2014.912238 |2 doi | |
| 035 | |a (DE-627)KFL001102869 | ||
| 035 | |a (KFL)prod_LgpH_10.3109/13880209.2014.912238 | ||
| 040 | |a DE-627 |b ger |c DE-627 |e rakwb | ||
| 041 | |a eng | ||
| 084 | |a PHARM |q DE-84 |2 fid | ||
| 100 | 1 | |a Grecco, Simone dos S |e verfasserin |4 aut | |
| 245 | 1 | 0 | |a Chemical composition andin vitrocytotoxic effects of the essential oil fromNectandra leucanthaleaves |c Simone dos S. Grecco, Euder Glendes A. Martins, Natália Girola, Carlos R. de Figueiredo, Alisson L. Matsuo, Marisi G. Soares, Bruno de C. Bertoldo, Patricia Sartorelli, João Henrique G. Lago |
| 264 | 1 | |c 2015 | |
| 300 | |a 1 Online-Ressource (5 p) | ||
| 336 | |a Text |b txt |2 rdacontent | ||
| 337 | |a Computermedien |b c |2 rdamedia | ||
| 338 | |a Online-Ressource |b cr |2 rdacarrier | ||
| 520 | |a Abstract Context: Nectandra (Lauraceae) species have been used in folk medicine as an antidiarrheal, analgesic, antifungal, etc., and have many pharmacological proprieties. Objective : Investigation of the chemical composition and cytotoxicity of essential oil from Nectandra leucantha Nees & Mart. leaves. This is the first study involving N. leucantha reported in the literature. Material and methods : The essential oil of N. leucantha leaves was obtained by hydrodistillation. Its chemical composition was determined using a combination of GC/FID, GC/MS, and determination of Kovats index (KI). In vitro cytotoxic activity was evaluated against six cancer cell lines – murine melanoma (B16F10-Nex2), human glioblastome (U-87), human cervical carcinoma (HeLa), human colon carcinoma (HCT), human breast adenocarcinoma (MCF7), and human cervical tumor (Siha) as well as against one non-tumorigenic cell line – human foreskin fibroblast (HFF). Results : Thirty-three compounds were identified primarily sesquiterpenes (81.41%), the main compounds being bicyclogermacrene (28.44%), germacrene A (7.34%), spathulenol (5.82%), and globulol (5.25%). Furthermore, monoterpenes were also found in the analyzed oil (12.84%), predominantly α- and β-pinenes (6.59 and 4.57%, respectively). The crude essential oil displayed significant cytotoxic activity against B16F10-Nex2 (IC 50 33 ± 1 μg/mL) and U87 (IC 50 75.95 ± 0.03 μg/mL) and HeLa (IC 50 60 ± 12 μg/mL) cell lines. The main identified compound, bicyclogermacrene, displayed IC 50 ranging from 3.1 ± 0.2 to 21 ± 6 μg/mL. Discussion and conclusion : The results indicate that the crude oils from leaves of N. leucantha displayed cytotoxic activity being bicyclogermacrene, the main compound identified in the crude oil responsible, at least in part, for this potential | ||
| 700 | 1 | |a Martins, Euder Glendes A. |e verfasserin |4 aut | |
| 700 | 1 | |a Girola, Natália |e verfasserin |4 aut | |
| 700 | 1 | |a de Figueiredo, Carlos R. |e verfasserin |4 aut | |
| 700 | 1 | |a Matsuo, Alisson L. |e verfasserin |4 aut | |
| 700 | 1 | |a Soares, Marisi G. |e verfasserin |4 aut | |
| 700 | 1 | |a Bertoldo, Bruno de C |e verfasserin |4 aut | |
| 700 | 1 | |a Sartorelli, Patricia |e verfasserin |4 aut | |
| 700 | 1 | |a Lago, João Henrique G. |e verfasserin |4 aut | |
| 773 | 0 | 8 | |i Enthalten in |t Pharmaceutical biology |d Abingdon : Taylor & Francis Group, 1961 |g 53(2015), 1, Seite 133- |h Online-Ressource |w (DE-627)KFL000005940 |w (DE-600)1483151-X |w (DE-576)273877747 |x 1744-5116 |7 nnns |
| 773 | 1 | 8 | |g volume:53 |g year:2015 |g number:1 |g pages:133- |
| 856 | 4 | 0 | |u http://pharmazie.proxy.fid-lizenzen.de/fid/tandf-ejournals-pharmazie/doi.org/10.3109/13880209.2014.912238 |m X:KFL |x Resolving-System |y FID Access |z lizenzpflichtig |
| 912 | |a ZDB-1-TFE | ||
| 912 | |a GBV_KFL | ||
| 912 | |a FID-PHARM | ||
| 912 | |a SSG-OLC-PHA | ||
| 935 | |i IMPORT_0628_prod_LgpH_01 | ||
| 951 | |a AR | ||
| 952 | |d 53 |j 2015 |e 1 |h 133- | ||